Delivery Order SPE2DB22D3016-SPE2DB24FBEG9

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.46 firm-fixed-price delivery order is for the supply of 4,568,143,760 units of the prescription medication Propranolol 20 mg tablets. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This federal contract award is a delivery order valued at $5,885.62 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,244,094 units of the drug Propranolol 20 mg tablet. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Propranolol 10mg tablets. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract has a ceiling value of $1,121.71...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,189.96 firm fixed-price delivery order is for the supply of 4,568,117,444 units of the prescription medication Propranolol ER 120 mg capsules. The contract has an ultimate completion date of May 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,209.06 firm fixed-price delivery order is for the supply of 100 units of 120 mg Propranolol ER capsules. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,618,158 units of Propranolol 10 mg tablets. The contract has a ceiling value of $1,381.05 and a period of performance through March 19, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,568,160 units of the prescription medication Propranolol 10 mg tablet. The contract has a firm fixed price of $1,242.75 and a performance period extending through May 7, 2025. This order is not set aside and represents an open competition award. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,829,127 units of Propranolol 20 mg tablets. The $2,614.07 contract has a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award (SPE2DB25D3005/SPE2DB25FQCQT) was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Propranolol 20 mg tablets. The $1,052.46 firm fixed-price contract has a completion date of February 20, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Propranolol 10 mg tablets. The $2,009.70 firm fixed-price contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBEG9
    Delivery Order

This contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) provides the Defense Logistics Agency (DLA) Troop Support Medical with 1,000 units of the prescription drug Propranolol 20 mg tablets. The $1,163.59 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen, which serves as the primary vehicle for the company to supply a range of medical commodities to support military treatment programs and facilities worldwide through December 2025. There is no set-aside designation for this specific award. This contract supports the healthcare needs of military personnel and other federal beneficiaries by providing essential pharmaceutical products.

Generated 11/15/24, 9:21 AM